1. Combination therapy for prostate cancer. Endocrine and biologic basis of its choice as new standard firstline therapy;Labrie, F.; Belanger, A.; Simard, J.; Labrie, C.; Dupont, A.;Cancer,1993
2. The role of neoadjuvant hormonal manipulation in localized prostatic cancer;Fair, W.R.; Aprikian, A.; Sogani, P.; Reuter, V.; Whitmore, W.F.;Cancer,1993
3. Experience with neoadjuvant diethylstilboestrol and radical prostatectomy in patients with locally advanced prostate cancer;Aprikian, A.G.; Fair, W.R.; Reuter, V.E.; Sogani, P.; Herr, H.; Russo, P.,1994
4. Perioperative hormonal therapy in locally advanced adenocarcinoma of the prostate;Graham, S.D.; Keane, T.E.; Petros, Sanders; W.H.;Cancer,1995
5. Programmed cell death during regression of PC-82 human prostate cancer following androgen ablation;Kyprianou, N.; English, H.F.; Isaacs, J.T.;Cancer Res,1990